Citigroup
NFH

Citigroup’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Citigroup’s Portfolio NFH Stock Details NFH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48,551
Closed -$556K – 6866
2021
Q4 		$556K Buy
+48,551
New +$547K ﹤0.01% 3715

Other funds holding NFH

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Citigroup's NFH Position: Q1 2022 in Review

Citigroup sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 48,551 shares — an estimated $556K sold.

Citigroup first reported a position in NFH in Q4 2021 and held it in 1 quarter. The position peaked at $556K in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

  • Citigroup reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Citigroup sold 48,551 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $556K.
  • Citigroup first reported a position in New Frontier Health Corporation Ordinary Shares in Q4 2021 and held it in 1 quarter.
  • Citigroup's New Frontier Health Corporation Ordinary Shares position peaked at $556K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.